CHINA PHARMA HOLDINGS, INC. Other Expenses
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Other Expenses of $126.81 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherExpenses · last filed 2018-05-14
- CHINA PHARMA HOLDINGS, INC. other expenses for the quarter ending 2018-03-31 was $126.81K, a 5.32% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. other expenses for the quarter ending 2017-09-30 was $108.87K, a 39.95% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. other expenses for the quarter ending 2017-06-30 was $125.89K, a 40.27% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. other expenses for the quarter ending 2017-03-31 was $133.93K.
- CHINA PHARMA HOLDINGS, INC. other expenses for fiscal 2016 was -$718.98K.
- CHINA PHARMA HOLDINGS, INC. other expenses for fiscal 2015 was -$1.05M, a 245.97% decline from fiscal 2014.
- CHINA PHARMA HOLDINGS, INC. other expenses for fiscal 2014 was $716.07K.
- CHINA PHARMA HOLDINGS, INC. other expenses for fiscal 2013 was -$340.24K.
| Period end | Other Expenses 3 month | Other Expenses 3 month as first filed | Other Expenses 6 month | Other Expenses 6 month as first filed | Other Expenses 9 month | Other Expenses 9 month as first filed | Other Expenses 12 month | Other Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $126.81K 10-Q · filed 2018-05-14 | |||||||
| 2017-09-30 | $108.87K 10-Q · filed 2017-11-14 | $234.76K derived: sum of 2 quarters · filed 2017-11-14 | $368.69K 10-Q · filed 2017-11-14 | -$951.08K derived: sum of 4 quarters · filed 2018-05-14 | ||||
| 2017-06-30 | $125.89K 10-Q · filed 2017-08-14 | $259.82K 10-Q · filed 2017-08-14 | -$1.06M derived: sum of 3 quarters · filed 2018-05-14 | -$878.64K derived: sum of 4 quarters · filed 2018-05-14 | ||||
| 2017-03-31 | $133.93K 10-Q · filed 2018-05-14 | -$133.93K 10-Q · filed 2017-05-11 | -$1.19M derived: sum of 2 quarters · filed 2018-05-14 | -$1.00M derived: sum of 3 quarters · filed 2018-05-14 | -$793.77K derived: sum of 4 quarters · filed 2018-05-14 | |||
| 2016-12-31 | -$1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$1.14M derived: sum of 2 quarters · filed 2017-11-14 | -$927.70K derived: sum of 3 quarters · filed 2017-11-14 | -$718.98K 10-K · filed 2017-03-31 | ||||
| 2016-09-30 | $181.31K 10-Q · filed 2017-11-14 | $392.07K derived: sum of 2 quarters · filed 2017-11-14 | $600.78K 10-Q · filed 2017-11-14 | -$1.68M derived: sum of 4 quarters · filed 2017-11-14 | ||||
| 2016-06-30 | $210.76K 10-Q · filed 2017-08-14 | $419.48K 10-Q · filed 2017-08-14 | -$1.87M derived: sum of 3 quarters · filed 2017-08-14 | -$1.62M derived: sum of 4 quarters · filed 2017-08-14 | ||||
| 2016-03-31 | -$208.72K 10-Q · filed 2017-05-11 | $208.72K 10-Q · filed 2016-05-16 | -$2.08M derived: sum of 2 quarters · filed 2017-05-11 | -$1.83M derived: sum of 3 quarters · filed 2017-05-11 | -$1.54M derived: sum of 4 quarters · filed 2017-05-11 | |||
| 2015-12-31 | -$1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$1.62M derived: sum of 2 quarters · filed 2017-03-31 | -$1.33M derived: sum of 3 quarters · filed 2017-03-31 | -$1.05M 10-K · filed 2017-03-31 | $1.05M 10-K · filed 2016-03-30 | |||
| 2015-09-30 | $242.93K 10-Q · filed 2016-11-14 | -$242.93K 10-Q · filed 2015-11-16 | $535.13K derived: sum of 2 quarters · filed 2016-11-14 | $822.05K 10-Q · filed 2016-11-14 | -$822.05K 10-Q · filed 2015-11-16 | $1.99M derived: sum of 4 quarters · filed 2016-11-14 | ||
| 2015-06-30 | $292.20K 10-Q · filed 2016-08-11 | -$292.20K 10-Q · filed 2015-08-14 | $579.12K 10-Q · filed 2016-08-11 | -$579.12K 10-Q · filed 2015-08-14 | $1.74M derived: sum of 3 quarters · filed 2016-08-11 | $1.43M derived: sum of 4 quarters · filed 2016-08-11 | ||
| 2015-03-31 | $286.92K 10-Q · filed 2016-05-16 | -$286.92K 10-Q · filed 2015-05-11 | $1.45M derived: sum of 2 quarters · filed 2016-05-16 | $1.13M derived: sum of 3 quarters · filed 2016-05-16 | $1.04M derived: sum of 4 quarters · filed 2016-05-16 | |||
| 2014-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $847.26K derived: sum of 2 quarters · filed 2016-03-30 | $750.73K derived: sum of 3 quarters · filed 2016-03-30 | $716.07K 10-K · filed 2016-03-30 | -$716.07K 10-K · filed 2015-03-30 | |||
| 2014-09-30 | -$316.42K 10-Q · filed 2015-12-28 | -$412.95K derived: sum of 2 quarters · filed 2015-12-28 | -$447.62K 10-Q · filed 2015-12-28 | -$528.96K derived: sum of 4 quarters · filed 2015-12-28 | ||||
| 2014-06-30 | -$96.53K 10-Q · filed 2015-12-28 | $96.53K 10-Q · filed 2014-08-14 | -$131.20K 10-Q · filed 2015-12-28 | $131.20K 10-Q · filed 2014-08-14 | -$212.54K derived: sum of 3 quarters · filed 2015-12-28 | -$299.55K derived: sum of 4 quarters · filed 2015-12-28 | ||
| 2014-03-31 | -$34.66K 10-Q · filed 2015-12-28 | -$116.00K derived: sum of 2 quarters · filed 2015-12-28 | -$203.01K derived: sum of 3 quarters · filed 2015-12-28 | -$111.98K derived: sum of 4 quarters · filed 2015-12-28 | ||||
| 2013-12-31 | -$81.34K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-28 | -$168.35K derived: sum of 2 quarters · filed 2015-12-28 | -$77.31K derived: sum of 3 quarters · filed 2015-12-28 | -$340.24K 10-K · filed 2015-12-28 | ||||
| 2013-09-30 | -$87.01K 10-Q · filed 2014-11-14 | $4.02K derived: sum of 2 quarters · filed 2014-11-14 | -$258.90K 10-Q · filed 2014-11-14 | -$147.82K derived: sum of 4 quarters · filed 2014-11-14 | ||||
| 2013-06-30 | $91.03K 10-Q · filed 2014-08-14 | -$91.03K 10-Q · filed 2013-08-14 | $171.89K 10-Q · filed 2014-08-14 | -$171.89K 10-Q · filed 2013-08-14 | -$60.81K derived: sum of 3 quarters · filed 2014-08-14 | -$138.73K derived: sum of 4 quarters · filed 2014-08-14 | ||
| 2013-03-31 | -$80.86K 10-Q · filed 2014-05-15 | -$151.84K derived: sum of 2 quarters · filed 2014-05-15 | -$229.76K derived: sum of 3 quarters · filed 2014-05-15 | -$307.44K derived: sum of 4 quarters · filed 2014-05-15 | ||||
| 2012-12-31 | -$70.98K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | -$148.90K derived: sum of 2 quarters · filed 2014-03-20 | -$226.58K derived: sum of 3 quarters · filed 2014-03-20 | -$303.43K 10-K · filed 2014-03-20 | ||||
| 2012-09-30 | -$77.92K 10-Q · filed 2013-11-14 | -$155.60K derived: sum of 2 quarters · filed 2013-11-14 | -$232.45K 10-Q · filed 2013-11-14 | |||||
| 2012-06-30 | -$77.68K 10-Q · filed 2013-08-14 | -$154.53K 10-Q · filed 2013-08-14 | ||||||
| 2012-03-31 | -$76.85K 10-Q · filed 2013-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |